Jefferies Group’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $8.74M | Buy |
1,269,100
+1,145,500
| +927% | +$7.96M | 0.07% | 216 |
|
|
2022
Q2 | $1.03M | Sell |
123,600
-61,800
| -33% | -$864K | 0.01% | 788 |
|
|
2022
Q1 | $4.24M | Sell |
185,400
-225,700
| -55% | -$5.52M | 0.03% | 459 |
|
|
2021
Q4 | $11.4M | Buy |
411,100
+232,500
| +130% | +$6.22M | 0.07% | 248 |
|
|
2021
Q3 | $4.97M | Buy |
+178,600
| New | +$5.06M | 0.04% | 436 |
|
|
2021
Q2 | – | Sell |
-106,300
| Closed | -$3.37M | – | 1672 |
|
|
2021
Q1 | $3.37M | Buy |
106,300
+36,300
| +52% | +$1.06M | 0.03% | 512 |
|
|
2020
Q4 | $1.46M | Buy |
+70,000
| New | +$1.31M | 0.01% | 814 |
|
|
2020
Q1 | – | Sell |
-479,300
| Closed | -$14.3M | – | 2073 |
|
|
2019
Q4 | $14.3M | Buy |
479,300
+122,400
| +34% | +$3.18M | 0.11% | 159 |
|
|
2019
Q3 | $7.8M | Buy |
356,900
+25,000
| +8% | +$572K | 0.06% | 312 |
|
|
2019
Q2 | $8.37M | Sell |
331,900
-111,600
| -25% | -$2.65M | 0.06% | 275 |
|
|
2019
Q1 | $11M | Sell |
443,500
-459,800
| -51% | -$11M | 0.09% | 185 |
|
|
2018
Q4 | $16.7M | Sell |
903,300
-306,700
| -25% | -$7.3M | 0.14% | 112 |
|
|
2018
Q3 | $31.1M | Sell |
1,210,000
-75,500
| -6% | -$1.73M | 0.2% | 76 |
|
|
2018
Q2 | $29.9M | Sell |
1,285,500
-583,400
| -31% | -$12.1M | 0.17% | 77 |
|
|
2018
Q1 | $29.8M | Sell |
1,868,900
-1,068,500
| -36% | -$19.9M | 0.16% | 75 |
|
|
2017
Q4 | $61M | Buy |
2,937,400
+2,374,400
| +422% | +$37.7M | 0.29% | 40 |
|
|
2017
Q3 | $8.07M | Sell |
563,000
-145,200
| -21% | -$2.2M | 0.05% | 350 |
|
|
2017
Q2 | $12.3M | Buy |
708,200
+64,800
| +10% | +$777K | 0.08% | 228 |
|
|
2017
Q1 | $7.1M | Sell |
643,400
-977,600
| -60% | -$13.4M | 0.05% | 368 |
|
|
2016
Q4 | $23.5M | Buy |
1,621,000
+271,100
| +20% | +$4.97M | 0.13% | 128 |
|
|
2016
Q3 | $33.1M | Sell |
1,349,900
-11,800
| -0.9% | -$305K | 0.17% | 94 |
|
|
2016
Q2 | $27.4M | Sell |
1,361,700
-286,700
| -17% | -$8.12M | 0.12% | 99 |
|
|
2016
Q1 | $43.4M | Buy |
1,648,400
+1,496,200
| +983% | +$111M | 0.25% | 46 |
|
|
2015
Q4 | $15.5M | Buy |
152,200
+133,700
| +723% | +$15M | 0.09% | 178 |
|
|
2015
Q3 | $3.3M | Buy |
+18,500
| New | +$4.31M | 0.02% | 672 |
|
|
2015
Q2 | – | Sell |
-45,800
| Closed | -$9.1M | – | 3294 |
|
|
2015
Q1 | $9.1M | Sell |
45,800
-394,300
| -90% | -$69.9M | 0.05% | 264 |
|
|
2014
Q4 | $63M | Buy |
440,100
+230,500
| +110% | +$31M | 0.37% | 52 |
|
|
2014
Q3 | $27.5M | Sell |
209,600
-285,700
| -58% | -$34.1M | 0.19% | 98 |
|
|
2014
Q2 | $62.5M | Buy |
+495,300
| New | +$63.2M | 0.53% | 30 |
|
|
2014
Q1 | – | Sell |
-85,900
| Closed | -$10.1M | – | 2030 |
|
|
2013
Q4 | $10.1M | Buy |
+85,900
| New | +$9.41M | 0.06% | 167 |
|
Other funds holding BHC
IC
PC
GAM
LCM
N
MP
Jefferies Group's BHC Position: Q3 2022 in Review
Jefferies Group increased its Bausch Health (BHC) stake by 218% in Q3 2022, buying an estimated $2.33M and bringing the position to 488,580 shares worth $3.37M. The position accounts for 0.03% of the portfolio, ranked #444.
Jefferies Group first reported a position in BHC in Q2 2013 and has held it in 34 quarters since. The position peaked at $62.5M in Q4 2014. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.
- Jefferies Group held 488,580 shares of Bausch Health worth $3.37M as of Q3 2022.
- Jefferies Group bought 334,985 Bausch Health shares in Q3 2022, an estimated $2.33M.
- Bausch Health made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #444 holding.
- Jefferies Group first reported a position in Bausch Health in Q2 2013 and has held it in 34 quarters since.
- Jefferies Group's Bausch Health position peaked at $62.5M in Q4 2014.
- 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.